With 76284.0 shares changed hands, the volume of the stock remained lighter than its average volume of 0.18 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $2.58 whereas the lowest price it dropped to was $2.34. The 52-week range on NUWE shows that it touched its highest point at $70.14 and its lowest point at $2.02 during that stretch. It currently has a 1-year price target of $462.00. Beta for the stock currently stands at -0.15.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NUWE was up-trending over the past week, with a rise of 6.17%, but this was down by -22.26% over a month. Three-month performance dropped to -53.47% while six-month performance fell -93.73%. The stock lost -94.83% in the past year, while it has lost -95.26% so far this year. A look at the trailing 12-month EPS for NUWE yields -107.66 with Next year EPS estimates of -1.87. For the next quarter, that number is -1.56. This implies an EPS growth rate of 92.72% for this year and 92.73% for next year. EPS is expected to grow by 84.72% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 90.39%.
Float and Shares Shorts:
At present, 1.36 million NUWE shares are outstanding with a float of 0.86 million shares on hand for trading. On 2025-11-14, short shares totaled 58344.0, which was 646.0000000000001 higher than short shares on 1760486400. In addition to Mr. John L. Erb as the firm’s Interim CFO, Interim Principal Financial & Accounting Officer, CEO, President and Chairman, Mr. Neil P. Ayotte Esq. serves as its Senior VP, General Counsel, Secretary & Chief Compliance Officer.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-09-30, NUWE reported revenue of $2217000.0 and operating income of -$2697000.0. The EBITDA in the recently reported quarter was -$2489000.0 and diluted EPS was $0.56.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$983.01 being high and -$983.01 being low. For NUWE, this leads to a yearly average estimate of -$983.01. The surprise factor in the prior quarter was -$18.06.
